Description

This curriculum spans the design and governance of quality systems across regulatory, operational, and cultural dimensions, equivalent in scope to a multi-phase internal capability program for establishing a compliant, risk-based quality management function in a regulated manufacturing environment.

Module 1: Defining Quality Assurance Frameworks Aligned with Regulatory Standards

Selecting between ISO 9001, ISO 13485, or IATF 16949 based on industry vertical and regulatory obligations
Mapping organizational processes to mandatory documentation requirements in FDA 21 CFR Part 820
Deciding whether to adopt a single integrated management system or maintain separate compliance frameworks
Establishing ownership for framework maintenance between QA, Legal, and Operations
Conducting gap assessments against current operations and target standard requirements
Designing document control hierarchies that satisfy both internal audit needs and external inspector expectations
Integrating risk management principles from ISO 14971 into core QA processes
Configuring version control protocols to ensure traceability during regulatory audits

Module 2: Governance of Quality Management System (QMS) Implementation

Selecting on-premise vs. cloud-based QMS platforms based on data sovereignty and validation requirements
Defining user access levels to prevent unauthorized changes while enabling cross-functional workflow
Validating electronic records and signatures per 21 CFR Part 11 with audit trail retention policies
Integrating QMS modules (CAPA, Deviations, Change Control) without creating siloed data repositories
Establishing escalation paths for non-conformance reports that bypass functional reporting lines
Designing periodic review cycles for SOPs with automated renewal and approval tracking
Implementing configuration management to prevent unapproved customization of QMS workflows
Coordinating internal audit schedules with external certification body timelines

Module 3: Risk-Based Decision Making in Quality Assurance

Applying FMEA to prioritize inspection frequency across manufacturing lines with limited QA resources
Setting risk acceptance thresholds for product release when test data is incomplete but within historical trends
Using risk scoring models to determine whether supplier audits are on-site or remote
Documenting rationale for waiving incoming inspection on critical raw materials from approved vendors
Aligning risk assessments with business continuity plans during supply chain disruptions
Calibrating audit depth based on process stability metrics and prior non-conformance history
Justifying reduced sampling plans under ANSI/ASQ Z1.4 with statistical process control evidence
Updating risk registers following post-market surveillance findings or customer complaints

Module 4: Supplier Quality Governance and Oversight

Developing supplier scorecards that balance quality performance with delivery and cost metrics
Deciding whether to audit high-risk suppliers annually or conditionally based on performance
Enforcing right-to-audit clauses in contracts with global contract manufacturers
Managing dual sourcing strategies while maintaining consistent quality specifications
Validating supplier test methods against internal lab capabilities to avoid discrepancies
Handling non-conforming materials from suppliers when production schedules are at risk
Requiring suppliers to maintain ISO certification and verifying status through independent databases
Implementing quarantine and disposition workflows for suspect materials pending investigation

Module 5: Change Control and Configuration Management

Classifying changes as minor, major, or critical based on impact to product safety and efficacy
Requiring cross-functional sign-offs for process changes affecting sterile manufacturing environments
Assessing need for re-validation after equipment recalibration or software patch deployment
Managing concurrent change requests that affect the same production line or product batch
Documenting technical rationale for deviations from approved change implementation timelines
Coordinating change control with regulatory submissions when modifications affect approved devices
Tracking configuration baselines for legacy products still in production
Enforcing freeze periods before regulatory audits or product submissions

Module 6: Internal Audit Program Design and Execution

Rotating auditors across departments to reduce familiarity bias while maintaining technical competence
Scoping audit plans to focus on high-risk processes identified in the annual risk assessment
Using checklists customized to specific regulations (e.g., EU MDR, GMP, AS9100)
Managing auditor independence when auditing matrix-managed teams
Documenting objective evidence for findings instead of relying on interview statements
Setting timelines for corrective actions based on severity and systemic implications
Tracking recurring findings to identify systemic training or process gaps
Reporting audit results directly to the quality committee, bypassing operational management

Module 7: Corrective and Preventive Action (CAPA) System Governance
Distinguishing between isolated incidents and systemic failures requiring CAPA initiation
Assigning CAPA ownership to individuals with authority to implement process changes
Verifying effectiveness checks are performed post-implementation with time-delayed data
Linking CAPA outcomes to management review metrics and performance goals
Preventing CAPA backlog by enforcing closure timelines and escalation protocols
Integrating customer complaint investigations with CAPA workflows to ensure root cause analysis
Using statistical tools (e.g., Pareto, fishbone) to validate root cause conclusions
Ensuring CAPA documentation withstands regulatory scrutiny during inspections

Module 8: Regulatory Inspection Preparedness and Response

Conducting mock inspections with external consultants to identify procedural weaknesses
Designating official spokespersons to prevent conflicting statements during FDA audits
Preparing document request response protocols with pre-approved access and redaction rules
Managing real-time note-taking and internal coordination during multi-day inspections
Classifying inspection observations (Form 483) by severity and assigning immediate response teams
Drafting response letters that commit to specific actions with verifiable completion dates
Coordinating legal review of inspection responses without delaying submission deadlines
Updating internal procedures post-inspection to prevent recurrence of cited issues

Module 9: Data Integrity and Audit Trail Management

Configuring system permissions to prevent deletion or alteration of raw analytical data
Validating chromatography data systems (CDS) to ensure audit trails capture all user actions
Defining retention periods for electronic records based on product shelf life and regulations
Implementing backup and recovery procedures that preserve metadata and timestamps
Training analysts to avoid common data integrity pitfalls like "testing into compliance"
Conducting periodic data integrity audits across laboratory and manufacturing systems
Documenting justification for manual data transcription when automated export is unavailable
Securing access to audit trail review functions to prevent tampering

Module 10: Continuous Improvement and Quality Culture Leadership

Setting quality KPIs (e.g., CAPA closure rate, audit finding recurrence) for executive dashboards
Aligning performance incentives with quality outcomes without encouraging underreporting
Conducting skip-level interviews to assess frontline perception of quality priorities
Integrating quality objectives into business unit strategic planning cycles
Launching targeted training based on trend analysis of non-conformances and deviations
Facilitating cross-departmental problem-solving sessions to break down silos
Communicating quality performance transparently, including failures and improvement efforts
Embedding quality gate reviews into project management lifecycles for new product introductions